Status:

COMPLETED

Effect of Intravenous Dexamethasone on Duration of Hyperbaric Bupivacaine Spinal Anesthesia in Lower Abdominal Surgery

Lead Sponsor:

Assiut University

Conditions:

Spinal Anesthesia

Eligibility:

All Genders

18-60 years

Phase:

PHASE2

Brief Summary

The use of dexamethasone, administered either systemically or perineurally, as an adjunct to peripheral or neuraxial regional blocks, is currently one of the hottest topics in the field of regional an...

Detailed Description

A large number of clinical studies have investigated this off-label application of dexamethasone in recent years, with many reporting enhanced sensory block and/or improved postoperative analgesia fol...

Eligibility Criteria

Inclusion

  • Patients with American Society of Anesthesiologists score I-III,
  • Patients undergoing lower abdominal surgery under hyperbaric bupivacaine spinal anesthesia

Exclusion

  • History of allergy to amide LAs or dexamethasone,
  • Presence of a preexisting lower limb neurological deficit
  • Chronic use of corticosteroids.

Key Trial Info

Start Date :

December 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2023

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04778189

Start Date

December 1 2021

End Date

May 1 2023

Last Update

May 25 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

faculty of medicine Assiut university

Asyut, Egypt

Effect of Intravenous Dexamethasone on Duration of Hyperbaric Bupivacaine Spinal Anesthesia in Lower Abdominal Surgery | DecenTrialz